MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Dec 18, 04:59 PM (EDT)
Price
$14.56
Change
+$0.08 (+0.55%)
Capitalization
12.48B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

a developer of pharmaceuticals

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for RDY with price predictions
Dec 17, 2024

RDY's RSI Oscillator ascending out of oversold territory

The RSI Indicator for RDY moved out of oversold territory on November 22, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In of the 21 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 05, 2024. You may want to consider a long position or call options on RDY as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on November 29, 2024. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where RDY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RDY broke above its upper Bollinger Band on December 05, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RDY entered a downward trend on December 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.833) is normal, around the industry mean (57.958). P/E Ratio (19.682) is within average values for comparable stocks, (89.727). Projected Growth (PEG Ratio) (4.879) is also within normal values, averaging (2.947). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (3.786) is also within normal values, averaging (19.472).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RDY is expected to report earnings to rise 20.46% to 21 cents per share on January 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q4'24
Est.
$0.21
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.06
Q4'23
Beat
by $0.10
The last earnings report on November 05 showed earnings per share of 17 cents, missing the estimate of 20 cents. With 1.61M shares outstanding, the current market capitalization sits at 12.48B.
A.I.Advisor
published Dividends

RDY paid dividends on August 12, 2024

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $4.78 per share was paid with a record date of August 12, 2024, and an ex-dividend date of July 30, 2024. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ETC.X32.416130-0.794762
-2.39%
Ethereum Classic cryptocurrency
PYR.X3.577170-0.158885
-4.25%
Vulcan Forged (PYR) cryptocurrency
MEME.X0.012580-0.000570
-4.33%
Memecoin cryptocurrency
FRONT.X0.433090-0.021224
-4.67%
Frontier cryptocurrency
GHST.X1.104465-0.080750
-6.81%
Aavegotchi cryptocurrency

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and TAK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
-1.43%
TAK - RDY
25%
Poorly correlated
+0.60%
SNDL - RDY
24%
Poorly correlated
+4.17%
TEVA - RDY
23%
Poorly correlated
+26.47%
ACET - RDY
23%
Poorly correlated
-0.75%
KMDA - RDY
23%
Poorly correlated
-0.86%
More